Cardinal Health Inc
XMUN:CLH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cardinal Health Inc
XMUN:CLH
|
US |
|
D
|
Digital Realty Trust Inc
SWB:FQI
|
US |
|
Iberdrola SA
LSE:0HIT
|
ES |
|
R
|
Reinet Investments SCA
JSE:RNI
|
LU |
|
Fujitsu Ltd
TSE:6702
|
JP |
Cardinal Health Inc
Cardinal Health is a major healthcare distributor and medical supply company. It buys prescription drugs and medical products from manufacturers, then moves them through its network to pharmacies, hospitals, clinics, and other care providers. It also sells its own line of medical and surgical supplies used in everyday patient care. The company makes money mainly by handling the flow of products through the healthcare system and by selling medical items to providers. Its customers include retail and hospital pharmacies, health systems, ambulatory surgery centers, and other organizations that need a reliable source of medicines, gloves, gowns, kits, and related supplies. A big part of its job is logistics, inventory management, and making sure products reach customers on time and in the right quantities. What makes Cardinal Health different is its role as a middle layer in healthcare. It does not mainly make the medicines patients take; instead, it connects drug makers and medical product suppliers with the providers who use those items every day. That makes it an important distribution and supply-chain partner in a business where speed, accuracy, and regulatory compliance matter a great deal.
Cardinal Health is a major healthcare distributor and medical supply company. It buys prescription drugs and medical products from manufacturers, then moves them through its network to pharmacies, hospitals, clinics, and other care providers. It also sells its own line of medical and surgical supplies used in everyday patient care.
The company makes money mainly by handling the flow of products through the healthcare system and by selling medical items to providers. Its customers include retail and hospital pharmacies, health systems, ambulatory surgery centers, and other organizations that need a reliable source of medicines, gloves, gowns, kits, and related supplies. A big part of its job is logistics, inventory management, and making sure products reach customers on time and in the right quantities.
What makes Cardinal Health different is its role as a middle layer in healthcare. It does not mainly make the medicines patients take; instead, it connects drug makers and medical product suppliers with the providers who use those items every day. That makes it an important distribution and supply-chain partner in a business where speed, accuracy, and regulatory compliance matter a great deal.
Beat and raise: Cardinal Health posted a strong Q3, with revenue up 11% to $61 billion and non-GAAP EPS up 35% to $3.17, then raised both full-year EPS and adjusted free cash flow guidance.
Pharma strength: The Pharmaceutical and Specialty Solutions segment again led results, with revenue up 11% to $56.1 billion and profit up 18% to $784 million, helped by strong specialty demand and GLP-1 growth.
Specialty momentum: Management said Specialty growth remained above 20% and expects Specialty revenue to exceed $50 billion in fiscal 2026, with oncology growing more than 30% in the quarter.
GMPD pressure: GMPD revenue was flat at $3.1 billion and profit fell to $25 million, hit by tariffs, though management said the improvement plan and Cardinal-branded product growth remain on track.
Cash and capital returns: Adjusted free cash flow was strong at $1.7 billion in the quarter, and year-to-date share repurchases reached $1 billion, above the company’s baseline target.
2027 tone: Management gave an early positive view on fiscal 2027, saying its long-term targets remain intact, while still flagging tariff, fuel, commodity and tax items as moving pieces.
